Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.87
+0.08 (0.30%)
At close: Aug 17, 2026, 4:00 PM EDT
26.83
-0.04 (-0.15%)
After-hours: Aug 17, 2026, 6:41 PM EDT

Pfizer Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,3347,7718,0312,11931,37221,979
Depreciation & Amortization
6,5396,5546,9946,2585,0285,104
Asset Writedown & Restructuring Costs
9,2425,3084,2613,440586363
Loss (Gain) From Sale of Investments
-1,870-----
Stock-Based Compensation
9477998775258721,182
Other Operating Activities
-3,742-3,349-4,342-1,485-2,946-8,943
Change in Accounts Receivable
-263-263-109347261-3,811
Change in Inventory
561561-854-1,169-591-1,125
Change in Accounts Payable
-469-469-1,023-3001,1911,242
Change in Other Net Operating Assets
-1,823-5,183-1,080-1,050-6,50016,498
Operating Cash Flow
13,40111,70412,7448,70029,26732,580
Operating Cash Flow Growth
-11.77%-8.16%46.48%-70.27%-10.17%126.20%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,416-2,629-2,909-3,907-3,236-2,711
Cash Acquisitions
-6,927-6,927--43,430-22,997-
Investment in Securities
3,7628,0405,56115,23910,642-19,517
Other Investing Activities
-104165--180-192-318
Investing Cash Flow
-5,685-1,3512,652-32,278-15,783-22,546

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--8,9077,6863,891-
Long-Term Debt Issued
-9,678-30,831-997
Total Debt Issued
5,9919,6788,90738,5173,891997
Short-Term Debt Repaid
--2,995-13,816-3-4,109-96
Long-Term Debt Repaid
--6,757-2,250-2,569-3,298-2,004
Total Debt Repaid
-4,213-9,752-16,066-2,572-7,407-2,100
Net Debt Issued (Repaid)
1,778-74-7,15935,945-3,516-1,103
Repurchase of Common Stock
-----2,000-
Common Dividends Paid
-9,785-9,771-9,512-9,247-8,983-8,729
Dividends Paid
-9,785-9,771-9,512-9,247-8,983-8,729
Other Financing Activities
-393-459-469-632-33516
Financing Cash Flow
-8,400-10,304-17,14026,066-14,834-9,816

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2241-66-40-165-59
Miscellaneous Cash Flow Adjustments
2--1--
Net Cash Flow
-66090-1,8102,449-1,515159

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
10,9859,0759,8354,79326,03129,869
Free Cash Flow Growth
-11.68%-7.73%105.19%-81.59%-12.85%145.29%
Free Cash Flow Margin
17.25%14.50%15.46%8.05%25.73%36.74%
Free Cash Flow Per Share
1.921.591.730.844.545.23
Levered Free Cash Flow
12,48613,43012,2791,66625,48630,940
Unlevered Free Cash Flow
14,17315,10014,2113,04626,26031,747

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2,7972,7393,2272,2151,4421,467
Cash Income Tax Paid
4,7344,6883,6053,1477,8677,427
Change in Working Capital
-1,994-5,354-3,066-2,172-5,63912,804
SEC Filings: 10-K · 10-Q